Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial

2009 ◽  
Vol 117 (3) ◽  
pp. 591-598 ◽  
Author(s):  
Elmar Stickeler ◽  
Maximilian Klar ◽  
Dirk Watermann ◽  
Annette Geibel ◽  
Martha Földi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Multicenter Phase ◽  
Line Therapy

Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients

2012 ◽  
Vol 35 (1) ◽  
pp. 18-21 ◽  
Author(s):  
Jean-Philippe Jacquin ◽  
Cyrus Chargari ◽  
Julie Thorin ◽  
Dominique Mille ◽  
Adrien Mélis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin ◽  
Breast Cancer Patients

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial

2008 ◽  
Vol 64 (2) ◽  
pp. 401-406 ◽  
Author(s):  
Peter Schmid ◽  
J. Krocker ◽  
R. Kreienberg ◽  
P. Klare ◽  
K. Kittel ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
Pegylated Liposomal Doxorubicin
Sign in / Sign up

Export Citation Format

Share Document